Life Sciences
Health Innovators – Matthew Holt
At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sat down with Matthew Holt, the founder and
The post Health Innovators – Matthew…
At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sat down with Matthew Holt, the founder and publisher of the Health Care Blog and a long-time self-described “digital health curmudgeon”.
In a freewheeling conversation, Jonah and Matt get into the nitty gritty of digital therapeutics and whether they should be following the paths of traditional therapeutics or blazing their own trail of new infrastructure.
For a long time, there was no debate on that topic, but as digital therapeutics have come into their own, DTx creators are questioning all the conventional wisdom, even as they take the steps they need to for regulation, reimbursement, and public trust.
They also talk about the age-old question of whether and how much AI can replace human physicians and therapists, now and in the future.
Check out the video below for the whole conversation, and stay tuned for more video interviews from Milan.
The post Health Innovators – Matthew Holt appeared first on .
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….